Long-Term Health and Quality of Life with ACRD
At a Glance
Long-term ACRD care uses individualized monitoring to protect growth and development, detect steroid effects on metabolism, bones, and adrenal function, and support emotional well-being, school, work, and the transition to adult care.
Living with Apparent Cortisone Reductase Deficiency (ACRD) is a long-term commitment to balance. Because the condition is rare and evidence is based on limited case reports, your care team will use a personalized surveillance plan to monitor your health or your child’s development over time [1][2].
Tracking Growth and Development
For children, a central goal of long-term monitoring is helping them reach their full height potential. Because excess androgens cause the skeleton to age too quickly, a child might be very tall for their age initially but stop growing years too early [1].
- Growth Velocity: Your endocrinologist will track height and weight regularly. A sudden drop in growth speed can be a sign that the medication dose is too high, while rapidly advancing “bone age” may mean the dose needs adjustment [1].
- Bone Age Monitoring: Periodic X-rays of the hand and wrist (bone age tests) are used to monitor skeletal maturation. The goal is to slow the bone aging process so that chronological age can catch up, as directed by your endocrinologist [1].
- Pubertal Progress: Doctors will monitor for signs of physical changes (like early body hair or acne) to ensure androgens are adequately managed [1].
Managing Long-Term Medication Risks
Because glucocorticoids—such as dexamethasone—are potent medications, taking them long-term requires careful monitoring for side effects, often referred to as “Cushingoid” effects [3][4].
| System | Potential Long-Term Effects | Monitoring Strategy (Tailored by Your Doctor) |
|---|---|---|
| Metabolism | Central weight gain, insulin resistance, and high blood sugar [3]. | Regular weight checks, blood pressure monitoring, and fasting glucose or HbA1c tests as recommended [4][3]. |
| Bone Health | Decreased bone density (osteoporosis) and increased fracture risk [5]. | Ensuring adequate calcium and Vitamin D; bone density (DXA) scans may be ordered based on cumulative dose, fracture history, and risk factors [6]. |
| Adrenal Health | The body’s own adrenal glands may become suppressed and stop producing cortisol naturally (medication-induced adrenal insufficiency) [7]. | A strict “sick-day plan” is required. If tapering medication, doctors use specific dynamic tests to ensure the glands have recovered their function [8]. |
Quality of Life and Daily Living
Living with a rare diagnosis can be socially and emotionally taxing. Patients and parents often face a high medication burden and frequent medical appointments, which can lead to fatigue or anxiety [9].
- Body Image: In both children and adults, physical signs like severe acne or excess hair can impact self-esteem and social confidence [10]. Working with a counselor or therapist who understands chronic illness can be very helpful.
- School and Activities: Parents should ensure school nurses are aware of the child’s condition and have a copy of the written “stress dose” or emergency plan for severe illness or major injury, if the child is on glucocorticoid therapy [7][8].
- Transition to Adulthood: As children with ACRD grow up, their treatment goals may shift from protecting height to managing fertility, skin health, or metabolic balance [2].
Because ACRD is a genetic condition, the best outcomes come from a strong partnership with your endocrinology team, combining your daily observations with their clinical expertise to keep your hormones safely balanced [1].
Common questions in this guide
Can ACRD treatment affect my child's final height?
What side effects should we watch for with long-term dexamethasone?
When might someone with ACRD need a bone density scan?
Why is a sick-day or stress-dose plan important in ACRD?
How do doctors decide whether ACRD treatment can be stopped?
How can ACRD affect daily life and emotional well-being?
Get notified when new evidence is published on Hyperandrogenism due to cortisone reductase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.
Zajkowska A, Rydzewska M, Wojtkielewicz K, et al.
Pediatric endocrinology, diabetes, and metabolism 2017; (23(1)):42-48 doi:10.18544/PEDM-23.01.0073.
PMID: 29073307 - 2
Alterations of Cortisol Metabolism in Human Disorders.
White PC
Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.
PMID: 29843121 - 3
Glucocorticoid prescribing in neurology.
Jones AP, Debono M, Walsh J, et al.
Practical neurology 2024; (24(4)):289-295 doi:10.1136/pn-2023-003855.
PMID: 38553045 - 4
Treatment and Follow-up of Non-stress Adrenal Insufficiency
Buğrul F, Özcan Murat N
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):93-101 doi:10.4274/jcrpe.galenos.2024.2024-6-23-S.
PMID: 39713906 - 5
Glucocorticoid-induced osteoporosis: Insights for the clinician.
Hayat S, Magrey MN
Cleveland Clinic journal of medicine 2020; (87(7)):417-426 doi:10.3949/ccjm.87a.19039.
PMID: 32605977 - 6
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR, Goemaere S, Verroken C, et al.
Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.
PMID: 35757436 - 7
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.
Beuschlein F, Else T, Bancos I, et al.
European journal of endocrinology 2024; (190(5)):G25-G51 doi:10.1093/ejendo/lvae029.
PMID: 38714321 - 8
Adrenal Insufficiency in Adults: A Review.
Vaidya A, Findling J, Bancos I
JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.
PMID: 40522647 - 9
Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I.
Goswami S, Peipert BJ, Helenowski I, et al.
Surgery 2017; (162(6)):1270-1277 doi:10.1016/j.surg.2017.07.023.
PMID: 28919050 - 10
Autoimmune Hepatitis in Children and Adolescents: Effect on Quality of Life.
Trevizoli IC, Pinedo CS, Teles VO, et al.
Journal of pediatric gastroenterology and nutrition 2018; (66(6)):861-865 doi:10.1097/MPG.0000000000001930.
PMID: 29470290
This page is for informational purposes only and does not constitute medical advice. Your endocrinology team should tailor growth, adrenal, and glucocorticoid monitoring to your or your child's needs.